Visionary Awards Luncheon


Join us on February 22, 2019 at the Julia Morgan Ballroom to honor Bay Area individuals who have made important advancements in medical research focused on breast cancer and Bay Area philanthropists who have generously donated to breast cancer and education programs.

Julia Morgan Ballroom

465 California St, San Francisco, CA 94104

11:00 Reception & Silent Auction

12:00 Luncheon and Program


Please join us in celebrating Bay Area Visionaries!

Can’t attend? Donate today and help us support breast cancer patients in the Bay Area.

Visionary Award Recipients

Melinda Telli, M.D. Stanford University School of Medicine

Eileen T. Consorti, M.D. Alta Bates Summit Medical Center

Pamela Munster, M.D. University of California, San Francisco


Philanthropist Award Recipients

Anette Harris

Patrick Barber, Compass

Mario Diaz, Wells Fargo Bank


Pam Judd Award Recipient

Vicki Kahn


Emmy Award winning broadcaster, Jan Yanehiro.

Sharon Seto



Your Impact

Our work is not done. Support of this event will help us reach our Bold Goal of reducing the current number of breast cancer deaths by 50% in the United States by 2026.

Funds raised at the Visionary Awards Luncheon will be invested in the Komen Treatment Assistance Fund. The Treatment Assistance Fund aims to help those who are facing financial challenges by providing limited financial assistance, education, and support services to low-income, underinsured or uninsured individuals in the eight counties that we serve; Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, and Sonoma counties. Funding helps patients of any age who have been diagnosed with breast cancer, at any stage of the disease.

In addition, 25 percent of funds raised at the Visionary Award Luncheon will be invested in the national Komen Grants Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific programs around the world. In 2014-15, Bay Area breast cancer researchers received more than $1.4 million from the Komen Research, Evaluation and Scientific Program.

Go to Top